ASF Standards · Ambulatory Clinic · Standard 20
Standard 20 — Psychiatry & Mental Health
Criteria in this standard
20.1 — Suicide Risk Screening Uses a Validated Tool, Applied Consistently
20.2 — Psychiatric Medication Management Follows a Defined Interaction and Monitoring Protocol
20.3 — Crisis Escalation Has a Defined, Immediate Pathway to Higher Level of Care
20.2 — Psychiatric Medication Management Follows a Defined Interaction and Monitoring Protocol
20.3 — Crisis Escalation Has a Defined, Immediate Pathway to Higher Level of Care
20.1
Suicide Risk Screening Uses a Validated Tool, Applied Consistently
Non-Negotiable
Every patient is screened for suicide risk using a validated, unmodified screening tool, with a documented, evidence-based follow-up process for anyone who screens positive — not an informal clinical impression in place of a structured, consistent process.
In plain terms: Every patient is screened for suicide risk with a validated tool used exactly as designed, and anyone who screens positive gets a defined, evidence-based follow-up.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Full | Full |
Why this matters
Most people who die by suicide have seen a healthcare provider in the preceding month. Many were never asked. A validated screen — Columbia Protocol, ASQ, PHQ-9 item 9 with follow-up — asks the question in a way that has been shown to identify risk without causing harm. 'Unmodified' matters: clinicians who soften the question, skip items, or use their own version lose the validation. A positive screen must lead somewhere: a same-day risk assessment, a safety plan, means restriction counselling, urgent referral if needed. A screen with no follow-up pathway is a question without an answer.
What good looks like
- A validated tool is used consistently, without informal modification.
- A positive screen triggers a defined, evidence-based follow-up assessment.
- Risk level is tied to a specific, written, individual mitigation plan.
Common failure modes
- Screening relies on informal clinical impression rather than a validated tool.
- A positive screen isn't followed by any defined next step.
- Risk is documented without any specific, individual mitigation plan attached.
Worked example
In practice
An outpatient psychiatry clinic seeing 200 patients a month.
BeforeSuicide risk was assessed by 'clinical judgment' during the interview. No standard tool. No documentation of the assessment in most records. A patient seen three days before his death had no documented suicide risk discussion. Staff said they 'always ask' but could not show it.
ActionThe Columbia Suicide Severity Rating Scale screener was adopted for every visit, administered verbatim by the clinician and documented. Positive screens trigger the full C-SSRS and a same-day risk formulation, a collaborative safety plan, means restriction counselling, and — by risk level — same-day psychiatrist review, crisis team referral, or emergency admission. A monthly audit checks screening completion and follow-up.
AfterThe Monitor reviewed 40 records: all had documented C-SSRS screens; six positives each had a full assessment, safety plan, and risk-appropriate action. Audit compliance 97%. Verified.
If you are starting from zero — do this first
- Pull 20 records: is suicide risk documented with a named tool?
- Adopt a validated screener and train every clinician to use it verbatim.
- Write the follow-up pathway by risk level.
- Audit monthly.
The most common mistake: Relying on 'clinical judgment' — clinicians consistently underestimate suicide risk in patients they know.
Self-assessment questions
1. Is every patient screened using a validated tool, administered without informal changes to its wording? — The tool exactly as validated, not adapted or shortened informally.
Evidence: Screening tool documentation
Evidence: Screening tool documentation
2. Does a positive screen trigger a defined, evidence-based follow-up assessment, not just a note in the chart? — A genuine, structured next step, not passive documentation alone.
Evidence: Follow-up assessment protocol
Evidence: Follow-up assessment protocol
3. Is the documented risk level tied to a specific, written mitigation plan for that patient? — A real, individual plan, not a generic statement that risk was assessed.
Evidence: Risk level and mitigation plan documentation
Evidence: Risk level and mitigation plan documentation
Common reasons for a PARTIAL answer
- The tool is used consistently but staff have informally shortened some questions to save time. — Even small wording changes have been shown to affect a validated tool's accuracy.
- Follow-up happens for clearly positive screens but is less consistent for borderline results. — A consistent, defined threshold protects against inconsistent judgement calls.
- A mitigation plan exists but isn't reviewed or updated at subsequent visits.
Implementation plan
| When | What |
|---|---|
| Week 1 | Confirm the screening tool used is validated and administered without informal modification. |
| Week 2 | Establish or reinforce a defined, evidence-based follow-up process for positive screens. |
| Week 3 | Ensure every documented risk level is tied to a specific, individual mitigation plan. |
| Ongoing | Review and update mitigation plans at subsequent visits. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Screening tool review | Reviews the screening tool used for validation status and confirms it's administered without informal modification. |
| DOCUMENT | Follow-up protocol review | Reviews the defined follow-up process for patients who screen positive. |
| DOCUMENT | Mitigation plan review | Reviews documentation linking risk level to a specific, individual mitigation plan. |
Supervisor tips
- Ask to see the exact screening tool used and confirm it matches the validated version, unmodified. — Direct comparison is the only way to confirm the tool hasn't been informally altered.
- Ask staff to describe the specific follow-up process for a positive screen. — A specific, confident answer reveals a genuine, defined process rather than case-by-case judgement.
Evidence base
[89] Established patient safety guidance on reducing the risk for suicide requires validated-tool screening for behavioral health patients, an evidence-based follow-up process for positive screens, and documented risk level with a written mitigation plan.
Train your team: AMB-20 · Psychiatry & Mental Health on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.
20.2
Psychiatric Medication Management Follows a Defined Interaction and Monitoring Protocol
Non-Negotiable
Psychiatric medication prescribing follows a defined process for checking interactions specific to psychotropic combinations, with required baseline and ongoing monitoring completed and reviewed — not prescribed based on symptom response alone, without the monitoring psychotropic medications specifically require.
In plain terms: Psychiatric prescribing follows a defined process for checking drug interactions specific to psychotropic combinations, with required baseline and ongoing monitoring done and reviewed.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Full | Full |
Why this matters
Psychiatric medications interact dangerously: serotonin syndrome from SSRI plus MAOI or tramadol; QT prolongation from antipsychotic combinations; lithium toxicity from an added NSAID or diuretic; clozapine agranulocytosis without blood monitoring. The monitoring is specific and non-negotiable: lithium levels, renal and thyroid function; clozapine white cell counts; antipsychotic metabolic monitoring (weight, glucose, lipids); ECG for QT-prolonging drugs. A clinic without a defined process — an interaction check at every prescription, a monitoring schedule per drug, a way to know when monitoring is overdue — will eventually have a preventable death.
What good looks like
- A specific process checks interactions for psychotropic combinations.
- Required baseline monitoring is genuinely completed before starting relevant medications.
- Ongoing monitoring is completed and reviewed at required intervals.
Common failure modes
- Interaction checking doesn't specifically address psychotropic combinations.
- Baseline monitoring is skipped or added only after a concern arises.
- Ongoing monitoring lapses or isn't reviewed even when technically completed.
Worked example
In practice
An outpatient psychiatry clinic with four prescribers and no shared monitoring system.
BeforeInteraction checking was by the prescriber's memory. Monitoring depended on the individual psychiatrist. The Coordinator found patients on lithium with no level for 14 months, patients on clozapine with lapsed blood monitoring, and a patient on three QT-prolonging drugs with no ECG. Nobody could say which patients were overdue.
ActionA prescribing process was implemented: an interaction check using a validated database documented at every new prescription or change; a monitoring schedule per high-risk drug (lithium, clozapine, antipsychotics, valproate) in a shared register with due dates; a monthly report of overdue monitoring reviewed by the clinical lead; ECG required before starting or combining QT-prolonging drugs. Prescriptions for patients with overdue monitoring are flagged and reviewed before renewal.
AfterThe Monitor reviewed the monitoring register (no patient overdue), 20 prescription records with documented interaction checks, and the monthly overdue report showing resolution of all flagged cases. Verified.
If you are starting from zero — do this first
- List every patient on lithium, clozapine, or valproate. When was their last monitoring?
- Build a monitoring register with due dates.
- Require a documented interaction check at every prescription.
- Review overdue monitoring monthly and pause renewals until done.
The most common mistake: Having each psychiatrist manage their own monitoring — the patient who changes doctor falls through the gap.
Self-assessment questions
1. Is there a defined process for checking interactions specific to psychotropic medication combinations? — A specific process for this medication class, not general interaction checking alone.
Evidence: Psychotropic interaction checking protocol
Evidence: Psychotropic interaction checking protocol
2. Is required baseline monitoring completed before starting medications that specifically require it? — Genuine baseline testing before starting, not added only if a concern later emerges.
Evidence: Baseline monitoring record
Evidence: Baseline monitoring record
3. Is ongoing monitoring completed and reviewed at the required intervals, not only at symptom-focused visits? — A defined, followed monitoring schedule, distinct from routine symptom check-ins.
Evidence: Ongoing monitoring schedule and review record
Evidence: Ongoing monitoring schedule and review record
Common reasons for a PARTIAL answer
- Interaction checking happens for new prescriptions but isn't rechecked when a second psychotropic medication is added later. — Interaction risk applies at the point combinations actually occur, not only at initial prescribing.
- Baseline monitoring is completed but results aren't reviewed before the medication is actually started. — A completed test that isn't reviewed before prescribing doesn't provide the intended protection.
- Ongoing monitoring is scheduled but appointments are sometimes missed without a specific follow-up process.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current interaction checking practice for psychotropic-specific coverage. |
| Week 2 | Establish or verify required baseline monitoring completion before starting relevant medications. |
| Week 3 | Establish a defined ongoing monitoring schedule with a specific follow-up process for missed appointments. |
| Ongoing | Audit monitoring completion and review against the required schedule. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Interaction checking protocol review | Reviews the specific process for checking psychotropic medication interactions. |
| DOCUMENT | Baseline monitoring review | Reviews records confirming required baseline monitoring is completed before starting relevant medications. |
| DOCUMENT | Ongoing monitoring review | Reviews adherence to the required ongoing monitoring schedule. |
Supervisor tips
- Ask what specific baseline monitoring is required for a commonly prescribed psychotropic medication here. — A specific, correct answer reveals genuine, current knowledge of monitoring requirements.
- Ask what happens when a patient misses a required monitoring appointment. — A specific, defined answer reveals whether this is genuinely tracked, not passively hoped for.
Evidence base
[90] Defined interaction checking and required baseline and ongoing monitoring specific to psychotropic medication classes, distinct from general medication safety practice, is established practice in psychiatric prescribing safety literature.
Train your team: AMB-20 · Psychiatry & Mental Health on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.
20.3
Crisis Escalation Has a Defined, Immediate Pathway to Higher Level of Care
Non-Negotiable
Staff have a defined, immediate escalation pathway for a patient in acute crisis, with a specific, named receiving facility for emergency psychiatric care, verified as genuinely functioning — not a general understanding that emergency services would be contacted if needed.
In plain terms: When a patient is in acute crisis, staff have an immediate, defined route to a named emergency psychiatric facility — tested and working, not a vague plan to 'get them to hospital.'
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Full | Full |
Why this matters
A patient who discloses an active suicide plan in the waiting room cannot be given an appointment next week. A patient in acute psychosis cannot be sent home in a taxi. The clinic must have a pathway: who assesses, who decides, which facility receives, how the patient gets there safely, and what happens if the facility says no. The receiving facility is named, the phone number is known, the relationship is tested. Staff must know they have the authority to act without waiting. A pathway that exists on paper but has never been used will fail under pressure.
What good looks like
- A specific, defined escalation pathway exists for acute crisis.
- A specific, named receiving facility relationship is confirmed and active.
- All clinical staff, not just the most senior, know the pathway confidently.
Common failure modes
- No specific pathway exists beyond general awareness that emergency services could be contacted.
- No specific receiving facility is named, only a general assumption.
- Only the most senior staff member present is confident in the escalation process.
Worked example
In practice
An outpatient psychiatry clinic 30 minutes from the nearest psychiatric inpatient unit.
BeforeCrisis management was ad hoc. A patient in acute crisis was told to 'go to the emergency department' and left alone; he did not go. Staff did not know who to call at the inpatient unit. The clinic had no relationship with the crisis team. No safe transport arrangement existed.
ActionA crisis pathway was written: immediate clinician assessment; risk-level decision; for high risk — patient not left alone, direct phone line to the inpatient unit's admissions doctor (agreed and tested), ambulance or crisis team transport arranged, handover documented; if the unit declines, escalation to the on-call consultant. The pathway is posted. A quarterly test call is made. Reception staff are trained to recognise crisis presentations and alert a clinician immediately.
AfterThe Monitor reviewed the pathway, the test call log, and three crisis events managed per pathway with documented handovers. Interviewed a receptionist who described the alert process. Verified.
If you are starting from zero — do this first
- Phone your nearest psychiatric unit now: who answers, and would they take a patient from you today?
- Write a crisis pathway with a named receiving facility and a direct number.
- Arrange safe transport — ambulance or crisis team, never a taxi alone.
- Train reception to recognise crisis and alert immediately.
The most common mistake: Telling a patient in crisis to go to the emergency department and assuming they will.
Self-assessment questions
1. Is there a specific, defined escalation pathway for a patient in acute crisis, not general awareness that help exists? — A specific, known pathway, not improvisation in the moment.
Evidence: Crisis escalation protocol document
Evidence: Crisis escalation protocol document
2. Is there a specific, named receiving facility for emergency psychiatric care? — A specific facility and relationship, not a general assumption somewhere would take the patient.
Evidence: Named receiving facility documentation
Evidence: Named receiving facility documentation
3. Do all clinical staff, not only the most senior, know the specific escalation steps confidently? — Genuine, distributed readiness, not knowledge held only by the most experienced person present.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
Common reasons for a PARTIAL answer
- The pathway is well understood by the primary psychiatrist but less consistently by other clinical staff. — A crisis can be first recognised by any staff member present, not only the psychiatrist.
- A receiving facility relationship exists but hasn't been reconfirmed as active recently. — Relationships can lapse without either party actively noticing.
- The pathway is known but has never been rehearsed as an actual drill.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current crisis escalation practice for a specific, defined pathway. |
| Week 2 | Confirm or establish a specific, named receiving facility relationship. |
| Week 3 | Brief all clinical staff, not only senior staff, on the specific escalation steps. |
| Ongoing | Periodically reconfirm the receiving facility relationship remains active. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Escalation pathway review | Reviews the specific, defined escalation pathway for completeness. |
| DOCUMENT | Receiving facility review | Reviews the specific, named receiving facility relationship for emergency psychiatric care. |
| ASK | Staff readiness interview | Asks a range of staff, not only the most senior, to describe the escalation pathway. |
Supervisor tips
- Ask a non-senior staff member to describe the escalation pathway. — This reveals whether readiness is genuinely distributed, not concentrated in one person.
- Ask for a real, recent example of the pathway being used, or a genuine drill. — A real example, or its honest absence, reveals whether this pathway genuinely functions under real conditions.
Evidence base
[91] A defined, verified escalation pathway to emergency psychiatric care, distinct from general awareness that emergency services exist, is established practice in outpatient behavioral health crisis management.
Train your team: AMB-20 · Psychiatry & Mental Health on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.